Yes, Guts, I like your phrase "on the verge of greatness", because what the chart is telling us and what the month-by-month revenue results are telling us are in harmony and in synchrony, especially because of the exceptional results being achieved in the compounding pharmacy sector. We could put it this way: we are already on the right side of the saucer formation, and the market is lagging in its recognition that SCRC has got over its convertible note problem and is now bound to benefit increasingly from its multiple sources of revenue. That adds up to saying that this the very best moment to make or to add to this investment. By the time we get to mid-2015 that will have become evident. I look forward to that – Tuscany beckons!